Announce Date | 07/23/2025 |
EPS Normalized Actual | $0.78 (Miss by $-0.001) |
EPS GAAP Actual | $0.78 (Miss by $-0.001) |
Revenue Actual | $4.52506B |
Revenue Surprise | Beat by $4525.06M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $12.38707 |
EPS GAAP Estimate | $12.38707 |
Revenue Estimate | $4.594541587B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 62.86 | 1.65 | 61.94799 | 63.82182 | 6 |
Dec 2028 | 68.84 | 1.51 | 66.66119 | 69.86534 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -7.99 | -20.4902 | 4.52506B | 5.59% | -90.81M |
FQ1 2025 (Mar 2025) | 9.4 | -0.68117 | 4.13692B | 3.88% | -47.38M |
FQ4 2024 (Dec 2024) | 9.56 | -0.28229 | 4.0956B | 6.44% | 10.18M |
FQ3 2024 (Sep 2024) | 11.47 | 11.47 | 4.36444B | 3.69% | 4364.44M |
FQ2 2024 (Jun 2024) | 10.61 | 10.61 | 4.2722B | 4.76% | 4272.2M |
FQ1 2024 (Mar 2024) | 9.27 | 9.27 | 3.97624B | 6.75% | 3976.24M |
FQ4 2023 (Dec 2023) | 9.33 | 9.33 | 3.83202B | 4.89% | 3832.02M |
FQ3 2023 (Sep 2023) | 10.82 | 10.82 | 4.20338B | 9.63% | 4203.38M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
12.38707
Consensus Revenue Estimates
4.594541587B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.87 | -- | 0.85574 | 0.88379 | 13 |
FQ3 2027 (Sep 2027) | 1.05 | -- | 1.03279 | 1.06664 | 9 |
FQ1 2027 (Mar 2027) | 0.79 | -- | 0.77705 | 0.80252 | 16 |
FQ4 2026 (Oct 2026) | 17.40723 | -- | 16.97747 | 17.65634 | 7 |
FQ3 2026 (Jul 2026) | 15.70323 | -- | 15.31554 | 15.92795 | 12 |
FQ1 2026 (Mar 2026) | 12.69458 | 25.95 | 12.56962 | 12.81392 | 8 |
FQ4 2025 (Oct 2025) | 13.22841 | 27.73 | 12.91535 | 13.38285 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.91B | -- | 4.85B | 4.97B | 19 |
FQ3 2027 (Sep 2027) | 5.34B | -- | 5.27B | 5.4B | 18 |
FQ1 2027 (Mar 2027) | 4.71B | -- | 4.65B | 4.77B | 16 |
FQ4 2026 (Oct 2026) | 5.16B | -- | 5.06B | 5.21B | 7 |
FQ3 2026 (Jul 2026) | 4.95B | -- | 4.86B | 5.01B | 12 |
FQ1 2026 (Mar 2026) | 4.49B | 7.92 | 4.46B | 4.53B | 7 |
FQ4 2025 (Oct 2025) | 4.75B | 13.75 | 4.66B | 4.79B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 12.5002 | -7.99 | -20.4902 | 256.45% |
FQ1 2025 (Mar 2025) | 10.08117 | 9.4 | -0.68117 | -7.25% |
FQ4 2024 (Dec 2024) | 9.84229 | 9.56 | -0.28229 | -2.95% |
FQ3 2024 (Sep 2024) | 11.47 | 11.47 | 100% | |
FQ2 2024 (Jun 2024) | 10.61 | 10.61 | 100% | |
FQ1 2024 (Mar 2024) | 9.27 | 9.27 | 100% | |
FQ4 2023 (Dec 2023) | 9.33 | 9.33 | 100% | |
FQ3 2023 (Sep 2023) | 10.82 | 10.82 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $4.62B | $4.53B | $-90.81M | -2.01% |
FQ1 2025 (Mar 2025) | $4.18B | $4.14B | $-47.38M | -1.15% |
FQ4 2024 (Dec 2024) | $4.09B | $4.1B | $10.18M | 0.25% |
FQ3 2024 (Sep 2024) | $0B | $4.36B | $4364.44M | 100% |
FQ2 2024 (Jun 2024) | $0B | $4.27B | $4272.2M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.98B | $3976.24M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.83B | $3832.02M | 100% |
FQ3 2023 (Sep 2023) | $0B | $4.2B | $4203.38M | 100% |